한글목차

세계의 아세트아미노펜 주사제 시장 규모는 2023년 7억 1,968만 달러에서 예측 기간 중 2.97%의 연평균 복합 성장률(CAGR)로 성장을 지속하여, 2030년에는 9억 1,204만 달러 규모로 성장할 것으로 예측됩니다.

북미 시장은 2023년 2억 7,780만 달러에서 2.37%의 연평균 복합 성장률(CAGR)로 성장을 지속하여, 2030년에는 3억 3,617만 달러에 이를 것으로 예측됩니다. 아시아태평양 시장은 2023년 1억 1,609만 달러에서 23.99%의 연평균 복합 성장률(CAGR)로 성장을 지속하여, 2030년에는 1억 6,058만 달러에 이를 것으로 예측됩니다. 유럽 시장은 2023년 2억 1,391만 달러에서 3.21%의 연평균 복합 성장률(CAGR)로 성장을 지속하여, 2030년에는 2억 7,299만 달러에 이를 것으로 예측됩니다.

세계의 아세트아미노펜 주사제 시장을 조사했으며, 시장 및 제품 개요, 각종 시장 성장 영향요인 분석, 시장 규모 추이와 예측, 유형·용도별 분석, 지역/주요 국가별 상세 분석, 경쟁 환경, 시장 점유율, 순위, 주요 기업 개요 등을 정리했습니다.

목차

제1장 시장 개요

• 아세트아미노펜 주사제 : 제품 개요
• 세계 시장 규모와 예측
• 시장 동향과 성장 촉진요인
  • 산업 동향
  • 시장 성장 촉진요인과 기회
  • 시장이 해결해야 할 과제
• 전제와 제한
• 조사 목적
• 조사 대상년도

제2장 경쟁 분석 : 기업별

• 주요 기업의 매출 순위
• 매출 : 기업별
• 주요 기업의 제조거점 분포 및 본사
• 주요 기업의 설립일
• 경쟁 분석
• 인수합병(M&A) 및 확장

제3장 유형별 부문

• 유형별 개요
  • 10mg/mL
  • 100mg/mL
  • 150mg/mL
• 판매액
  • 판매액수 : 2019년 vs. 2023년 vs. 2030년
  • 판매액 추이·예측
  • 판매액 추이·예측(%)

제4장 용도별 부문

• 용도별 개요
  • 병원
  • 진료소
• 판매액
  • 판매액수 : 2019년 vs. 2023년 vs. 2030년
  • 판매액 추이·예측
  • 판매액 추이·예측(%)

제5장 지역별 부문

• 판매액
  • 판매액수 : 2019년 vs. 2023년 vs. 2030년
  • 판매액 추이
  • 판매액 예측
  • 판매액 추이·예측(%)
• 북미
• 유럽
• 아시아태평양
• 남미·중동 및 아프리카

제6장 주요 국가/지역별 부문

• 주요 국가/지역별 성장 동향 : 2019년 vs. 2023년 vs. 2030년
• 주요 국가, 지역별 판매액·판매 수량
• 미국
• 유럽
• 중국
• 일본
• 한국
• 인도

제7장 기업 개요

• Mallinckrodt
• Sandoz
• Pfizer
• Fresenius Kabi
• Terumo
• B. Braun Medical Inc
• Eugia
• Accord Healthcare
• Hikma

제8장 산업 체인 분석

• 산업 체인
• Upstream 분석
• Midstream 분석
• Downstream 분석(고객 분석)
• 판매 모델과 판매 채널

제9장 조사 결과 및 결론

제10장 부록

영문목차

The global market for Acetaminophen Injection was estimated to be worth US$ 719.68 million in 2023 and is forecast to a readjusted size of US$ 912.04 million by 2030 with a CAGR of 2.97% during the forecast period 2024-2030.

North American market for Acetaminophen Injection was valued at $ 277.80 million in 2023 and will reach $ 336.17 million by 2030, at a CAGR of 2.37% during the forecast period of 2024 through 2030.

Asia-Pacific market for Acetaminophen Injection was valued at $ 116.09 million in 2023 and will reach $ 160.58 million by 2030, at a CAGR of 3.99% during the forecast period of 2024 through 2030.

Europe market for Acetaminophen Injection was valued at $ 213.91 million in 2023 and will reach $ 272.99 million by 2030, at a CAGR of 3.21% during the forecast period of 2024 through 2030.

The global key companies of Acetaminophen Injection include Hikma, Sandoz, Mallinckrodt, B. Braun Medical Inc, Eugia, Fresenius Kabi, Pfizer, Accord Healthcare, and Terumo, etc. In 2023, the global three largest players hold a share approximately 66.67% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Acetaminophen Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acetaminophen Injection by region & country, by Type, and by Application.

The Acetaminophen Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetaminophen Injection.

Market Segmentation

By Company

• Mallinckrodt
• Sandoz
• Pfizer
• Fresenius Kabi
• Terumo
• B. Braun Medical
• Eugia
• Accord Healthcare
• Hikma

Segment by Type

• 10 mg/ mL
• 100 mg/mL
• 150 mg/mL

Segment by Application

• Hospital
• Clinic

By Region

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Rest of Europe
• Latin America & Middle East & Africa
• Latin America
• Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Acetaminophen Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Acetaminophen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Acetaminophen Injection in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Acetaminophen Injection Product Introduction
• 1.2 Global Acetaminophen Injection Market Size Forecast (2019-2030)
• 1.3 Acetaminophen Injection Market Trends & Drivers
  • 1.3.1 Acetaminophen Injection Industry Trends
  • 1.3.2 Acetaminophen Injection Market Drivers & Opportunity
  • 1.3.3 Acetaminophen Injection Market Challenges
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Acetaminophen Injection Players Revenue Ranking (2023)
• 2.2 Global Acetaminophen Injection Revenue by Company (2019-2024)
• 2.3 Key Companies Acetaminophen Injection Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Established Date
• 2.5 Acetaminophen Injection Market Competitive Analysis
  • 2.5.1 Acetaminophen Injection Market Concentration Rate (2019-2024)
  • 2.5.2 Global 5 Largest Companies by Acetaminophen Injection Revenue in 2023
  • 2.5.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acetaminophen Injection as of 2023)
• 2.6 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 10 mg/ mL
  • 3.1.2 100 mg/mL
  • 3.1.3 150 mg/mL
• 3.2 Global Acetaminophen Injection Sales Value by Type
  • 3.2.1 Global Acetaminophen Injection Sales Value by Type (2019 VS 2023 VS 2030)
  • 3.2.2 Global Acetaminophen Injection Sales Value, by Type (2019-2030)
  • 3.2.3 Global Acetaminophen Injection Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
• 4.2 Global Acetaminophen Injection Sales Value by Application
  • 4.2.1 Global Acetaminophen Injection Sales Value by Application (2019 VS 2023 VS 2030)
  • 4.2.2 Global Acetaminophen Injection Sales Value, by Application (2019-2030)
  • 4.2.3 Global Acetaminophen Injection Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

• 5.1 Global Acetaminophen Injection Sales Value by Region
  • 5.1.1 Global Acetaminophen Injection Sales Value by Region: 2019 VS 2023 VS 2030
  • 5.1.2 Global Acetaminophen Injection Sales Value by Region (2019-2024)
  • 5.1.3 Global Acetaminophen Injection Sales Value by Region (2025-2030)
  • 5.1.4 Global Acetaminophen Injection Sales Value by Region (%), (2019-2030)
• 5.2 North America
  • 5.2.1 North America Acetaminophen Injection Sales Value, 2019-2030
  • 5.2.2 North America Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
• 5.3 Europe
  • 5.3.1 Europe Acetaminophen Injection Sales Value, 2019-2030
  • 5.3.2 Europe Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Acetaminophen Injection Sales Value, 2019-2030
  • 5.4.2 Asia Pacific Acetaminophen Injection Sales Value by Region (%), 2023 VS 2030
• 5.5 South America , Middle East & Africa
  • 5.5.1 South America , Middle East & Africa Acetaminophen Injection Sales Value, 2019-2030
  • 5.5.2 South America, Middle East & Africa Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Acetaminophen Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
• 6.2 Key Countries/Regions Acetaminophen Injection Sales Value, 2019-2030
• 6.3 United States
  • 6.3.1 United States Acetaminophen Injection Sales Value, 2019-2030
  • 6.3.2 United States Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 United States Acetaminophen Injection Sales Value by Application, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe Acetaminophen Injection Sales Value, 2019-2030
  • 6.4.2 Europe Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe Acetaminophen Injection Sales Value by Application, 2023 VS 2030
• 6.5 China
  • 6.5.1 China Acetaminophen Injection Sales Value, 2019-2030
  • 6.5.2 China Recent Developments
• 6.6 Japan
  • 6.6.1 Japan Acetaminophen Injection Sales Value, 2019-2030
  • 6.6.2 Japan Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 Japan Acetaminophen Injection Sales Value by Application, 2023 VS 2030
• 6.7 South Korea
  • 6.7.1 South Korea Acetaminophen Injection Sales Value, 2019-2030
  • 6.7.2 South Korea Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 South Korea Acetaminophen Injection Sales Value by Application, 2023 VS 2030
• 6.8 India
  • 6.8.1 India Acetaminophen Injection Sales Value, 2019-2030
  • 6.8.2 India Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • 6.8.3 India Acetaminophen Injection Sales Value by Application, 2023 VS 2030

7 Company Profiles

• 7.1 Mallinckrodt
  • 7.1.1 Mallinckrodt Profile
  • 7.1.2 Mallinckrodt Main Business
  • 7.1.3 Mallinckrodt Acetaminophen Injection Products, Services and Solutions
  • 7.1.4 Mallinckrodt Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.1.5 Mallinckrodt Recent Developments
• 7.2 Sandoz
  • 7.2.1 Sandoz Profile
  • 7.2.2 Sandoz Main Business
  • 7.2.3 Sandoz Acetaminophen Injection Products, Services and Solutions
  • 7.2.4 Sandoz Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.2.5 Sandoz Recent Developments
• 7.3 Pfizer
  • 7.3.1 Pfizer Profile
  • 7.3.2 Pfizer Main Business
  • 7.3.3 Pfizer Acetaminophen Injection Products, Services and Solutions
  • 7.3.4 Pfizer Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
• 7.4 Fresenius Kabi
  • 7.4.1 Fresenius Kabi Profile
  • 7.4.2 Fresenius Kabi Main Business
  • 7.4.3 Fresenius Kabi Acetaminophen Injection Products, Services and Solutions
  • 7.4.4 Fresenius Kabi Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.4.5 Fresenius Kabi Recent Developments
• 7.5 Terumo
  • 7.5.1 Terumo Profile
  • 7.5.2 Terumo Main Business
  • 7.5.3 Terumo Acetaminophen Injection Products, Services and Solutions
  • 7.5.4 Terumo Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
• 7.6 B. Braun Medical Inc
  • 7.6.1 B. Braun Medical Inc Profile
  • 7.6.2 B. Braun Medical Inc Main Business
  • 7.6.3 B. Braun Medical Inc Acetaminophen Injection Products, Services and Solutions
  • 7.6.4 B. Braun Medical Inc Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
• 7.7 Eugia
  • 7.7.1 Eugia Profile
  • 7.7.2 Eugia Main Business
  • 7.7.3 Eugia Acetaminophen Injection Products, Services and Solutions
  • 7.7.4 Eugia Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.7.5 Eugia Recent Developments
• 7.8 Accord Healthcare
  • 7.8.1 Accord Healthcare Profile
  • 7.8.2 Accord Healthcare Main Business
  • 7.8.3 Accord Healthcare Acetaminophen Injection Products, Services and Solutions
  • 7.8.4 Accord Healthcare Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
• 7.9 Hikma
  • 7.9.1 Hikma Profile
  • 7.9.2 Hikma Main Business
  • 7.9.3 Hikma Acetaminophen Injection Products, Services and Solutions
  • 7.9.4 Hikma Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.9.5 Hikma Recent Developments

8 Industry Chain Analysis

• 8.1 Acetaminophen Injection Industrial Chain
• 8.2 Acetaminophen Injection Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Acetaminophen Injection Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Acetaminophen Injection Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer